Anders Ståhlberg is a new professor of clinical genomics

Akademiliv congratulates Anders Ståhlberg on his professorship in clinical genomics! His research group focuses on developing new treatments for sarcomas driven by fusion oncogenes and on developing new cancer diagnostics by analyzing blood-based biomarkers. The goal is to develop targeted therapies for sarcoma and to be able to tailor treatments over time to minimize overtreatment and undertreatment. To enable these goals, ultra-sensitive DNA and RNA analyzes are developed and used, and Anders Ståhlberg leads a Translational Genomic Platform that aims to implement these techniques in clinical routine. Anders Ståhlberg participates in teaching within the medical, dental and biomedical analysts program.